Perinatal drug abuse in KK women's and children's hospital

Annals of the Academy of Medicine Singapore

Volumn 28, Issue 6, 1999, Pages 795-799

  Agarwal, P ^a   Rajadurai, V S ^a   Bhavani, S ^a   Tan, K W ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

High risk maternal profile; Neonatal abstinence syndrome; Substance abuse; Toxicology screening

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; FETUS; HIGH RISK POPULATION; HUMAN; NEWBORN; PERINATAL DRUG EXPOSURE; RISK FACTOR; SCREENING; SELF REPORT; SINGAPORE; SMOKING; SUBSTANCE ABUSE; TOXICITY TESTING; URINALYSIS; WITHDRAWAL SYNDROME;

EID: 0033398333     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chasnoff I J. Drug use and women: Establishing a standard care. Ann NY Acad Sci 1989; 562:208-10.
2. Chasnoff I, Burns K A, Burns W J, Schnoll S H. Prenatal drug exposure: Effects on neonatal and infant growth and development. Neurobehav Toxicol Teratol 1986; 8:357-62.
3. Naeye R L, Blanc W, Leblanc W, Khatamee M A. Fetal complications of maternal heroin addiction: Abnormal growth, infections and episodes of stress. J Pediatr 1973; 83:1055-61.
4. Stone M L, Salerno LJ, Green M, Zelson C. Narcotic addiction in pregnancy. Am J Obstet Gynecol 1973; 109:716-23.
5. Le Jeune C, Ropet J C, Montaimat S, Floch-Todal C, Mazy F, Wijkhuisen N, et al. Medical-social outcome of 59 infants born to addicted mothers (articles in French). J Gynecol Obstet Biol Reprod (Paris) 1997; 26:395-404.
6. Acker D, Sachs B P, Tracy KJ, Wise W E. Abruptio placentae associated with cocaine use. Am J Obstet Gynecol 1983; 146:220-1.
7. Evans A T, Gillogley K. Drug use in pregnancy: Obstetric perspectives. Clin Perinatol 1991; 18:23-32.
8. Zelson M, Lee S J, Casalino M. Neonatal narcotic addiction. N Engl J Med 1973; 289:1216-20.
9. Bcll G L, Lau K. Perinatal and neonatal issues of substance abuse. Pediatr Clin N Am 1995; 42:261-90.
10. Chasnoff I J. Drug use in pregnancy parameters of risk. Pediatr Clin N Am 1988; 35:1403-12.
11. Kandall SR. Late complications in passively addicted infants. In: Rementeria J O, editor. Drug Abuse in Pregnancy and the Neonate. St Louis, CV: Mosby Co, 1977:116.
12. Lam S K, To W K, Duthie S J, Ma H K. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. Aust NZJ Obstet Gynaecol 1992; 32:216-21.
13. Struthers J M, Hansen R L. Visual recognition memory in drug exposed infants. J Dev Behav Pediatr 1992; 13:108-11.
14. Chasnoff I J, Schnoll S H, Burns W J, Burns K A. Maternal non narcotic substance abuse during pregnancy: Effects on infant development. Neurobehav Toxicol Teratol 1984; 6:277-80.
15. Billing L, Erisksson M, Larsson G, Zeller Strom R. Amphetamine addiction and pregnancy III. One year follow up of the children: Psychosocial and pediatric aspects. Acta Pediatr Scand 1980; 69:675-80.
16. Finnegan L, Kron R E, Connaughton J, Errich J. A scoring system for the evaluation and treatment of neonatal abstinence syndrome: A new clinical and research tool. In: Manelli P L, Garatric S, Sussi F, editors. Basic and Therapeutic Aspects of Perinatal Pharmacology. New York: Raven Press, 1975.
17. Woolf A D, Shannon M W. Clinical toxicology for the paediatrician. Pediatr Clin N Am 1995; 42:317-33.
18. Chasnoff I J, Landress H J, Barrett M E. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990; 322:1202-6.
19. Ong T H, Isralowitz R E. Substance Use in Singapore: Illegal Drugs, Inhalants and Alcohol. Singapore: Toppan Co, 1996.
20. Misuse of drugs (amendment) act passed with the third reading [newspaper article]. Singapore: Lianhe Zaobao 1993 Nov 11; p19.
21. Ostrea E M, Brady M, Gause S, Raymundo A L, Stevens M. Drug screening of new borns by meconium analyses. Alarge scale prospective epimediologic study. Pediatrics 1992; 89:107-13.
22. Funkhouser A W, Butz A M, Feng T I, McCaul ME, Rosenstein B J. Prenatal Care and drug use in pregnant women. Drug Alcohol Depend 1993; 33:1-9.
23. Heogerman G, Scholl S. Narcotic use in pregnancy. Clin Perinat 1991; 18:51-76.
24. Gillogley K M, Evans A T, Hansen R L, Samuels S J, Batra K K. Perinatal impact of cocaine, amphelamine and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol 1990; 163:1535-42.
25. Ochs H D. The human immunodeficiency virus-infected infant. A diagnostic dilema [editorial]. Am J Dis Child 1989; 143:1138-9.
26. Boer K, Smit B J, Van Hius A M, Hogerzil H V. Substance use in pregnancy: Do we care? Acta Pediatr Suppl 1994; 404:65-71.
27. Alroomi L G, Davidson J, Evans T J, Galea P, Howat R. Maternal narcotic abuse and the newborn. Arch Dis Child 1988; 63:81-3.
28. Vance J C, Chant D C, Tudchope D I, Gray P H, Hayes A J. Infants born to narcotic dependent mothers: Physical growth patterns in the first 12 months of life. J Paediatr Child Health 1997; 33:504-18.
29. Finnegan L P, Kron R E, Connaughton J F, Errich J. Neonatal abstinence syndrome: Assessment and management. Addictive Diseases: An International Journal 1975; 2:141-58.
30. Theis J G, Selby P, Ikizler Y, Koren G. Current management of the neonatal abstinence syndrome: A critical analysis of the evidence. Biol Neonate 1997; 71:345-6.
31. Halstead A C, Godolphin W, Lockitch G, Segal S. Timing of specimens is crucial in urine screening of drug dependent mothers and infants. Clin Biochem 1988; 21:59-61.
32. Ostrea M E, Brady M J, Parks P M, Asensio D C, Naluz A. Drug screening of meconium in infants of drug dependent mother: An alternative to urine testing. J Pediatr 1989; 115:474-7.
33. Specht E E, Bourguet C C. Predictors of non attendance at the First Newborn Health Supervisor visit. Clin Paediatr 1994; 33:273-9.